Transaction in Own Shares

Summary by AI BETAClose X

On September 4, 2025, GSK plc announced the purchase of 232,912 of its own ordinary shares, each with a nominal value of 31¼ pence, on September 3, 2025. The shares were bought through Merrill Lynch International, with prices ranging from 1,445.50p to 1,466.00p per share and a volume-weighted average price of 1,456.20p. These shares will be held as treasury shares as part of an existing buyback program, bringing the total treasury share count to 245,165,050. Since June 4, 2025, GSK has purchased 27,030,667 ordinary shares. Following this transaction, the total number of voting rights in the company is 4,070,231,046, and the percentage of voting rights attributable to treasury shares is 6.02 percent.

Disclaimer*

Companies

GSK (GSK)
UK 100

Latest directors dealings